| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024671825 |
| P356 | DOI | 10.1186/AR2717 |
| P932 | PMC publication ID | 2714134 |
| P698 | PubMed publication ID | 19497113 |
| P5875 | ResearchGate publication ID | 26267357 |
| P50 | author | Hans-Erik Claesson | Q57050325 |
| Olof Rådmark | Q64750530 | ||
| P2093 | author name string | Karina Roxana Gheorghe | |
| Per-Johan Jakobsson | |||
| Marina Korotkova | |||
| Anca Irinel Catrina | |||
| Linda Backman | |||
| Erik af Klint | |||
| P2860 | cites work | Interaction of human 15-lipoxygenase-1 with phosphatidylinositol bisphosphates results in increased enzyme activity | Q24307726 |
| Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase | Q24563459 | ||
| Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells | Q24648965 | ||
| Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis | Q57349771 | ||
| Synovitis reduced by inhibition of leukotriene B4: Carragheenan-induced gonarthritis studied in dogs | Q61711836 | ||
| Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis | Q67867727 | ||
| Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo | Q69057699 | ||
| 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4) | Q69350027 | ||
| Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate | Q69350339 | ||
| Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13 | Q70971532 | ||
| The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis | Q71620541 | ||
| Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo | Q71773557 | ||
| Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture | Q72396938 | ||
| Increased serum leukotriene B4 level in the active stage of rheumatoid arthritis in children | Q73195415 | ||
| 15-Lipoxygenase expression and 15(S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects | Q73651109 | ||
| Arachidonate 15-lipoxygenase of reticulocyte-type in human rheumatoid arthritis type B synoviocytes and modulation of its activity by proinflammatory cytokines | Q77762605 | ||
| Inhibited aortic aneurysm formation in BLT1-deficient mice | Q80500137 | ||
| Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages | Q93536217 | ||
| B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis | Q94702098 | ||
| Functional classes of bronchial mucosa genes that are differentially expressed in asthma | Q24795231 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution | Q28183175 | ||
| New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases | Q28222356 | ||
| Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes | Q28240849 | ||
| 5-Lipoxygenase metabolites inhibit bone formation in vitro | Q28275044 | ||
| Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids | Q28321995 | ||
| Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis | Q28366047 | ||
| 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB. | Q30438056 | ||
| High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes | Q33398788 | ||
| Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis | Q33554843 | ||
| Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis | Q33578241 | ||
| Inhibition of eicosanoid biosynthesis by glucocorticoids in humans | Q33783999 | ||
| Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins | Q33903345 | ||
| Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells | Q33948003 | ||
| Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators | Q34282093 | ||
| The role of leukotrienes in inflammation | Q34324567 | ||
| Corticosteroids: the drugs to beat | Q34488032 | ||
| The two faces of the 15-lipoxygenase in atherosclerosis | Q34687589 | ||
| IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression | Q35866426 | ||
| Neutrophil-derived leukotriene B4 is required for inflammatory arthritis | Q36228578 | ||
| Inflammation and immune regulation by 12/15-lipoxygenases | Q36469920 | ||
| Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases | Q37888849 | ||
| Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis | Q39702734 | ||
| Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B). | Q40567462 | ||
| 5-Lipoxygenase upregulation by dexamethasone in human mast cells | Q40911812 | ||
| The neutrophil in rheumatoid arthritis. | Q40976141 | ||
| Dexamethasone Increases Expression of 5‐Lipoxygenase and its Activating Protein in Human Monocytes and THP‐1 Cells | Q41110058 | ||
| Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids | Q41277804 | ||
| Human B lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4. | Q41674889 | ||
| Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells | Q43607825 | ||
| Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis | Q44391513 | ||
| Cooperative induction of 15-lipoxygenase in rheumatoid synovial cells by IL-4 and proinflammatory cytokines. | Q44740046 | ||
| Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium | Q44930014 | ||
| Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta | Q46766143 | ||
| Prednisolone in early rheumatoid arthritis: an antiinvasive effect | Q46778824 | ||
| Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels | Q46829587 | ||
| Expression of 15-lipoxygenase type-1 in human mast cells | Q50335981 | ||
| Enhancement of leukotriene A4 biosynthesis in neutrophils from patients with rheumatoid arthritis after a single glucocorticoid dose. | Q54015381 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | R83 | |
| P577 | publication date | 2009-06-04 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids | |
| P478 | volume | 11 |
| Q34208803 | 5-Lipoxygenase inhibitors attenuate TNF-α-induced inflammation in human synovial fibroblasts |
| Q51171205 | A Multinational Arab Genome-Wide Association Study Identifies New Genetic Associations for Rheumatoid Arthritis. |
| Q55191136 | Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? |
| Q42099776 | Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis |
| Q30318026 | Conventional basis therapy of rheumatoid arthritis. Effects within and outside cells |
| Q39147426 | Critical Role of LTB4/BLT1 in IL-23-Induced Synovial Inflammation and Osteoclastogenesis via NF-κB. |
| Q38828358 | Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver |
| Q36218707 | Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model |
| Q46047625 | High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis |
| Q60951626 | How Glucocorticoids Affect the Neutrophil Life |
| Q39067604 | Immune resolution mechanisms in inflammatory arthritis |
| Q64100827 | In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis |
| Q46288360 | Increased 15-lipoxygenase-1 expression in chondrocytes contributes to the pathogenesis of osteoarthritis. |
| Q42936280 | Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked |
| Q56670240 | Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants |
| Q48236372 | Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia. |
| Q36246027 | Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue |
| Q36208046 | Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS |
| Q36225451 | Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers |
| Q38098220 | Mast cells: from lipid droplets to lipid mediators |
| Q38186997 | Persisting eicosanoid pathways in rheumatic diseases |
| Q38211488 | Pharmacology of intra-articular triamcinolone |
| Q90026306 | Pro- and anti-inflammatory eicosanoids in psoriatic arthritis |
| Q27334082 | Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis |
| Q58778332 | Resolution of chronic inflammatory disease: universal and tissue-specific concepts |
| Q100503949 | Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice |
| Q43464822 | Targeting leukotriene B4 in inflammation |
| Q35896489 | The effects of joint aspiration and intra-articular corticosteroid injection on flexion reflex excitability, quadriceps strength and pain in individuals with knee synovitis: a prospective observational study |
Search more.